NEW YORK, May 19, 2015 /PRNewswire/ -- The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions. Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implica-tions of these trends are influencing product development method-ology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process.
The value we provide to our clients and subscribers is best illustrated by our ability to consistently provide strategic direction and market knowledge that contributes to their tactical and strategic decision process.
Market-driven Product Strategies
'A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.'
What You Will Learn
What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?
What are the market drivers influencing syringe and injector device designs, feature/functionality, product branding, competing technologies and commercial development?
What are the key characteristics of the major injection device market segments and what is the impact of market demographics, and competing business strategies?
What is the current market for syringe and injector demand by indication and therapy and what will it be in 2022?
Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?
Read the full report: http://www.reportlinker.com/p01622517-summary/view-report.html
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001